首页> 外文期刊>Inorganica Chimica Acta >Synthesis and characterization of functionalized thymidine as a potential carrier for cisplatin-like drugs
【24h】

Synthesis and characterization of functionalized thymidine as a potential carrier for cisplatin-like drugs

机译:功能化胸苷作为顺铂样药物潜在载体的合成与表征

获取原文
获取原文并翻译 | 示例
       

摘要

Pursuing the idea of using a biological nanovector to drive the non-specific cytotoxic activity of Pt(II) complexes toward biological targets, we have singled out thymidine (T) as a potential biological carrier for delivery of cisplatin-like drugs to DNA. Thymidine was functionalized by first reacting it with solid sodium hydride and 1,3-diiodopropane, producing high yields of N3-iodopropylthymidine. Further reaction with ethylenediamine gave the bio-ligand N3-(3-ethylenediamine)propylthymidine which reacts in turn with K2PtCl4, resulting in a cisplatin-like nucleoside.This derivative (or more soluble analogues) can be phosphorylated by the cellular enzyme pool and incorporated into the growing DNA chain, thus making them suitable candidates as potential antiproliferative agents, exploiting both alkylating and antimetabolite mechanisms. (c) 2005 Elsevier B.V. All rights reserved.
机译:遵循使用生物纳米载体来驱动Pt(II)复合物的非特异性细胞毒活性朝着生物靶标的想法,我们已经选出胸苷(T)作为将顺铂样药物递送至DNA的潜在生物载体。首先使胸苷与固体氢化钠和1,3-二碘丙烷反应,从而使其官能化,从而获得高产率的N3-碘丙基胸苷。与乙二胺进一步反应得到生物配体N3-(3-乙二胺)丙基胸苷,后者与K2PtCl4反应,生成顺铂样核苷,该衍生物(或更易溶的类似物)可被细胞酶池磷酸化并掺入进入成长中的DNA链,从而使其成为烷基化和抗代谢机制的潜在候选抗增殖剂。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号